Sponsor Pipeline

Arthrosi Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06846515 Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) Gout Active, Not Recruiting
Phase 2
NCT07116746 Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment… Gout Active, Not Recruiting
Get alerts when Arthrosi Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free